H19 and congenital bilateral aplasia of vas deferens from CFTR mutation: Mathieu et al. revealed that a dysregulation of DNA methylation in the promoter of H19, which promotes an osteogenic differentiation of VICs by interfering with expression of NOTCH1 during CAVD [6].